As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...
Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results